Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CG-P5 peptide by Caregen for Wet (Neovascular / Exudative) Macular Degeneration: Likelihood of Approval
CG-P5 peptide is under clinical development by Caregen and currently in Phase I for Wet (Neovascular / Exudative) Macular Degeneration....